Article: Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Viral Eye Infection.

Article: Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases.
PR Newswire;  February 20, 2008 ;     542 words ......license with Sirion Therapeutics, Bridge has...medical needs. Forward-Looking Statements This press...contains forward-looking statements and information about Sirion Therapeutics, Inc.'s and...products. These forward-looking ...

Article: Sirion Therapeutics Initiates Enrollment of Phase II Clinical Trial for the Treatment of Geographic Atrophy.
PR Newswire;  December 4, 2006 ;     401 words ......PRNewswire/ -- Sirion Therapeutics, Inc., an...acquired by Sirion in July of...Officer of Sirion Therapeutics, Inc. Fenretinide...Butler. About Sirion Therapeutics, Inc. Sirion Therapeutics is a Tampa...regarding Sirion and the matters...please visit ...

Article: Sirion Therapeutics Initiates Enrollment of Phase III Clinical Trials for the Treatment of Inflammation Following Ocular Surgery.
PR Newswire;  January 22, 2007 ;     481 words ......Holdings, Inc. Sirion Therapeutics is a Tampa...siriontherapeutics.com/. Forward-Looking Statements This press...Inc.'s and Sirion Therapeutics, Inc.'s business...schedule. These forward-looking statements are only...and such forward-looking ...

Article: Sirion Therapeutics, Inc. Combines With Tenby Pharma Inc.
PR Newswire;  September 18, 2006 ;     700+ words ......acquisition of Sirion Therapeutics, Inc. as...and CEO of Sirion Therapeutics, Inc., has...Officer of Sirion Therapeutics, and Barry...strategic goals. Sirion Therapeutics has been...Inc. and Sirion Therapeutics, Inc. Tenby...company for Sirion ...

Article: Sirion Therapeutics Preclinical Studies: Two New Potential Advances in Treatment of Retinal Diseases to be Presented at ARVO.
PR Newswire;  April 21, 2008 ;     700+ words ......Therapeutics, Inc. Sirion Therapeutics is a privately...siriontherapeutics.com/. Forward-Looking Statements This press...may contain forward-looking statements based on...management of Sirion Therapeutics. Various...update these ...

Article: Sirion Therapeutics.(TAMPA)
Florida Trend;  June 1, 2007 ;     19 words ...>> Sirion Therapeutics, an ophthalmic-focused pharmaceutical company, received $45 million in private equity financing.

Article: Sirion Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare Conference.
PR Newswire;  September 1, 2006 ;     189 words ...TAMPA, Fla., Sept. 1 /PRNewswire/ -- Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical...software download that may be necessary. About Sirion Therapeutics Sirion Therapeutics is a Tampa, FL based biopharmaceutical...

Article: Sirion Therapeutics Completes $45 Million Series B Financing.
PR Newswire;  April 9, 2007 ;     477 words ...TAMPA, Fla., April 9 /PRNewswire/ -- Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical...Barry Butler, President and CEO of Sirion Therapeutics, said that the proceeds from this...the brand name of Virgan(R). About Sirion Therapeutics, Inc. Sirion ...

Article: Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound.
PR Newswire;  July 24, 2006 ;     323 words ...TAMPA, Fla., July 24 /PRNewswire/ -- Sirion Therapeutics, Inc., an ophthalmic-focused pharmaceutical...license agreement were not disclosed. About Sirion Therapeutics, Inc. Sirion Therapeutics is a Tampa, FL based company dedicated...

Article: Tenby Pharma Changes Corporate Name to Sirion Holdings.
PR Newswire;  November 30, 2006 ;     295 words ......recent transaction whereby Sirion Therapeutics, Inc. became a wholly owned...and operating subsidiary, Sirion Therapeutics, Inc., said Susan Benton, Chief Commercial Officer of Sirion Therapeutics. About Sirion Holdings and...

Article: Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation.
PR Newswire;  February 27, 2008 ;     546 words ...TAMPA, Fla., Feb. 27 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focus...FDA) and granted priority review. Sirion Therapeutics is seeking approval from the FDA...Durezol(TM) is the trademark of Sirion Therapeutics Inc. and is currently under review...

Article: Sirion Therapeutics Merges With Sytera to Develop New Treatments For Eye Disease.
PR Newswire;  August 16, 2006 ;     688 words ...TAMPA, Fla., Aug. 16 /PRNewswire/ -- Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical...newly merged company will be named Sirion Therapeutics, Inc., and Barry Butler will serve...serve the company as a member of the Sirion Therapeutics Board of Directors. Kevin J. ...

Article: Sirion Therapeutics Initiates Two Phase III Clinical Trials.
PR Newswire;  May 1, 2007 ;     338 words ...TAMPA, Fla., May 1 /PRNewswire/ -- Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical...our development programs to date. About Sirion Therapeutics, Inc. Sirion Therapeutics is an ophthalmic biopharmaceutical company...

Article: Sirion Therapeutics Supports Ophthalmic Education.
PR Newswire;  September 28, 2007 ;     426 words ......TAMPA, Fla., Sept. 28 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic...treatment of ophthalmic disease. About Sirion Therapeutics, Inc. Sirion Therapeutics is a privately held biopharmaceutical...